Interesting Engineering on MSN13d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentThe FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Until Insulet's Omnipod came on the market at the end of 2005, all insulin pumps consisted of a controller and insulin reservoir attached to the injection site by a long flexible tube. The Omnipod ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, Mariposa, California and United States ...
The U.S. Food and Drug Administration announced that Sanofi-Aventis U.S. LLC's Merilog (insulin-aspart-szjj) becomes the first rapid-acting insulin biosimilar product to get its ...
It may also cause other common side effects such as injection site reactions ... "For the millions of people who rely on daily injections of insulin for treatment of diabetes, having a biosimilar ...
Some also affect blood sugar or insulin response ... bloating), fatigue and headache. Injections can also cause injection-site reactions such as redness and pain. Side effects are most common ...
Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes: Maryland Monday, February 17, 202 ...
Hosted on MSN14d
I felt isolated in shame after learning I had diabetes. Doing my insulin shots in public helped me accept it.I needed to run to the bathroom for an insulin shot before the appetizers arrived ... The bulky device clipped into my bra and was tethered to the injection site by a long, clear tube that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback